Development and Validation of a Chromatographic Ultraviolet Method for the Simultaneous Quantification of Dolutegravir and Rilpivirine in Human Plasma-Reference-Cited by-同舟云学术

Development and Validation of a Chromatographic Ultraviolet Method for the Simultaneous Quantification of Dolutegravir and Rilpivirine in Human Plasma

Published:2016-06 Issue:3 Volume:38 Page:407-413
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Cozzi Valeria,Charbe Nitin,Baldelli Sara,Castoldi Simone,Atzori Chiara,Cattaneo Dario,Clementi Emilio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference23 articles.

1. Long-term immunological outcomes in treated HIV-infected individuals in high-income and low-middle income countries;Achhra;Curr Opin HIV AIDS,2011

2. Rilpivirine: drug profile of a second-generation non-nucleoside reverse transcriptase HIV-inhibitor;Ripamonti;Expert Rev Anti Infect Ther,2014

3. TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1;Azijn;Antimicrob Agents Chemother,2010

4. Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir;Canducci;J Infect Dis,2011

5. The activity of the integrase inhibitor dolutegravir against HIV-1 variants isolated from raltegravir-treated adults;Underwood;J Acquir Immune Defic Syndr,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Different effects of the companion antiretroviral drugs on dolutegravir trough concentrations;AIDS;2024-01-15

2. Development and validation of an HPLC method for quantification of dolutegravir in human plasma;Biomedical Chromatography;2023-08-22

3. Effect of doravirine on dolutegravir trough concentrations in people with HIV switched from darunavir/cobicistat;Journal of Antimicrobial Chemotherapy;2023-04-18

4. Simultaneous quantification of (E) and (Z) isomers of rilpivirine and four degradation products in bulk and tablets by reversed‐phase ultra‐high‐performance liquid chromatography and confirmation of all by molecular weight;Journal of Separation Science;2023-04-14

5. METHOD DEVELOPMENT AND VALIDATION FOR THE ANALYSIS OF DOLUTEGRAVIR IN PURE AND DOSAGE FORMS USING ULTRAVIOLET-VISIBLE SPECTROSCOPY;Indian Drugs;2023-04-07